Therapeutic Advances In Ophthalmology impact factor, indexing, ranking (2024)

Aim and Scope

The Therapeutic Advances In Ophthalmology is a research journal that publishes research in the field of vision science, ophthalmology, eye diseases. This journal is published by the SAGE Publishing. The ISSN of this journal is .

Also, please check the following important details about therapeutic advances in ophthalmology: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

The ISSN (International Standard Serial Number) is an 8-digit code used to uniquely identify journals. ISSN numbers are assigned by a network of ISSN National Centres, usually located at national libraries and coordinated by the ISSN International Centre based in Paris. The International Centre is an intergovernmental organization created in 1974 through an agreement between UNESCO and the French government.

Important Metrics

therapeutic advances in ophthalmology Indexing

The therapeutic advances in ophthalmology is indexed in:

• UGC CARE
• Web of Science (ESCI)
• DOAJ
• PubMed

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).

Note: ESCI journals donot come with an impact factor. However, ESCI journals are evaluated every year and those who qualified are transferred to SCIE.

Therapeutic Advances In Ophthalmology Impact Factor 2024

The latest impact factor of therapeutic advances in ophthalmology is N/A.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.

Note: Every year, The Clarivate releases the Journal Citation Report (JCR). The JCR provides information about academic journals including impact factor. The latest JCR was released in June, 2023. The JCR 2024 will be released in the June 2024.

Publication fee

Based on the Official Journal Homepage, the therapeutic advances in ophthalmology does not charge any publication fee.

An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.

Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Therapeutic Advances In Ophthalmology?

If your research is related to vision science, ophthalmology, eye diseases, then visit the official website of therapeutic advances in ophthalmology and send your manuscript.

Tips for publishing in Therapeutic Advances In Ophthalmology:

• Selection of research problem.
• Presenting a solution.
• Designing the paper.
• Make your manuscript publication worthy.
• Write an effective results section.
• Mind your references.

Acceptance Rate

Journal Publication Time

The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the therapeutic advances in ophthalmology publishes research articles in 12 weeks on an average.

Final Summary